[Diabetic patients after myocardial infarction]

D Tschöpe1

  • 1Diabeteszentrums am Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität, Georgstrasse 11, 32545 Bad Oeynhausen, Germany.

Zeitschrift Fur Kardiologie
|March 17, 2004
PubMed

Insights

Diabetes mellitus significantly increases cardiovascular risk and is a precursor to heart attacks. Aggressively managing diabetes and related factors can substantially lower cardiovascular event risk in high-risk patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Context:

  • Diabetes mellitus is a primary driver of global cardiovascular disease incidence.
  • It represents maximal risk for target organ damage, particularly the cardiovascular system.
  • Diabetes is often an unrecognized precursor to myocardial infarction and sudden cardiac death.

Purpose:

  • To highlight the profound impact of diabetes mellitus on cardiovascular health.
  • To underscore the elevated mortality and morbidity risks associated with diabetes post-myocardial infarction.
  • To present evidence supporting intensive management of diabetes and cardiovascular risk factors.

Summary:

  • Diabetes mellitus is not merely a risk factor but defines maximal cardiovascular risk.
  • Approximately 75% of patients post-myocardial infarction (MI) have impaired glucose tolerance or diabetes.
  • Data indicate that elevated risks in diabetics persist beyond the initial cardiovascular event.

Impact:

  • The STENO-2 trial demonstrates that intensive management of diabetes and cardiovascular risk factors significantly reduces cardiovascular events.
  • This approach offers a tangible strategy to mitigate severe outcomes in a high-risk diabetic population.
  • Effective management can substantially lower the incidence of cardiovascular events and improve long-term prognosis for diabetic patients.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...